Meeting Materials

ACBSCT Meeting: September 25, 2020

Click the links below to download the material.

Click on the links below to access the PowerPoints for this meeting.

HRSA Division of Transplantation Blood Stem Cell Transplantation Program Update
Frank Holloman, Director, Division of Transplantation (DoT), Health Resources and Services Administration

Blood Stem Cell Transplantation Trends: An Overview
Stephen Spellman, MBS, Director, Immunobiology Research, National Marrow Donor Program (NMDP)

Haploidentical Transplantation: An Overview
Mary Eapen, MBBS, MS, Senior Scientific Director of Research Operations, Center for International Blood and Marrow Transplant Research

Mismatched Bone Marrow Transplantation: An Overview
Stephen Spellman, MBS, Director, Immunobiology Research, National Marrow Donor Program (NMDP)

A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologic Malignancies
Claudio Brunstein, MD, PhD, Program Director, Adult Blood and Marrow Transplantation Program, University of Minnesota

Cord Blood Derived Virus Specific T Cells
Catherine Bollard, MD, MBChB, Director, Center for Cancer and Immunology, Director, Program for Cell Enhancement and Technologies for Immunotherapy, Children’s National Hospital

Cord Blood Derived CAR NK Cells
Katy Rezvani, MD, PhD, Director of Translational Research, Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX

Cord Blood in Regenerative Medicine
Joanne Kurtzberg, MD, Jerome S. Harris Distinguished Professor of Pediatrics, Duke University School of Medicine

Cord Blood Transplantation: Challenges and Opportunities (Baker’s Presentation; Milano’s Presentation)
Juliet Barker, MBBS, Memorial Sloan Kettering Cancer Center; Filippo Milano, M.D., Fred Hutchinson Cancer Research Center

CAR- T Cell Immunotherapies
Sergio Giralt, MD, Deputy Division Head, Division of Hematologic, Malignancies, Memorial Sloan Kettering Cancer Center

CCR5 Genotype
Mary J. Laughlin, MD, Medical Director, Cleveland Cord Blood Center

COVID-19: Impact on Blood Stem Cell Transplantation
Kristine Naruko, CHTC, Vice President, Provider Services Operations, National Marrow Donor Program;
Ray Hornung, MBA, Senior Manager, Logistics Emergency Preparedness, National Marrow Donor Program


Skip to content